Covid 19 Vaccine: Access, Preparedness and Information

November 18, 2020

In response from community leaders around the world, senior representatives from the WHO and civil society presented an initial briefing on COVID-19 vaccines and the strategies for equitable access and community engagement.

Click to read the the key takeaways in English or French.

The WHO Team has also answered all the audience questions. You can see their responses here Download
  • Lisa Menning
  • Brian Tisdall
  • Andy Seale
W.H.O. panelists, from left to right: Lisa Menning– Team lead (acting), Demand and behavioural sciences, Department of Immunization, Vaccines, and Biologicals (IVB), WHO, Brian Tisdall– Lead, Communities and civil society, Access to COVID-19 Tools Accelerator’ (ACT-A) hub, WHO, Andy Seale– Advisor, WHO and co-lead, Working Group on Community and Civil Society Engagement on the Global Action Plan on healthy lives and well-being for all.

  • Karrar Karrar
  • Anna Marriott
Panelists Karrar Karrar– Access to Medicines Advisor, Save the Children UK and Anna Marriott– Health Policy Advisor, Oxfam GB and the People’s Vaccine Alliance 

The 5 Goals of MCLD

  • Voice and Agency for Women, Youth and All Marginalized Groups.
  • Adequate Community Finance: a fair share, at least 20%, of public budgets.
  • Good Local Governance: democratically elected, autonomous, skilled, participatory, transparent, effective.
  • Quality, Affordable Public Services: health, education, water, sanitation, vocational training, food and nutrition security, natural resource management, public safety and justice.
  • Resilience: disaster preparedness and risk-reduction, resilient to climate change and social/political disruptions.